Versor Investments’s Acceleron Pharma XLRN Stock Holding History

Versor Investments’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-401,208	Closed	-$69M	–	695
2021 Q3	$69M	Buy	+401,208	New	+$52.5M	2.12%	18

Versor Investments's XLRN Position: Q4 2021 in Review

Versor Investments sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 401,208 shares — an estimated $69M sold.

Versor Investments first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $69M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Versor Investments reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Versor Investments sold 401,208 Acceleron Pharma shares in Q4 2021, an estimated $69M.
Versor Investments first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Versor Investments's Acceleron Pharma position peaked at $69M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Versor Investments's 13F filing for Q4 2021, filed 8 Feb 2022.